Sunday, September 26, 2021
wellness India Expo
Home Tags TB

Tag: TB

Treating TB with engineered hydrogel implants: A fresh approach to drug...

The Tuberculosis Gel is non-immunogenic, implantable under the skin and can release these four drugs (in the therapeutic range) for a prolonged period (up to 15 days in mice)................................

Fujifilm India launches national campaign on Tuberculosis

An initiative in association with National TB Elimination Programme (NTEP), Fujifilm India plans to fill the critical gap in TB screening by providing mobile x-ray facility in selected pockets...................................

TB Alliance’s ZeNix trial in South Africa & Eastern Europe shows...

New trial results show effectiveness of BPaL regimen for highly drug-resistant TB can be maintained with reduced dosing of Linezolid.....................................

Vital Strategies releases public education resources to accelerate govt’s END TB...

On World TB Day, Vital Strategies has released two new communication resources to support the Government of India’s effort to END TB once and for all.........................

Dr Harsh Vardhan appointed as Chairman of ‘Stop TB Partnership Board’

Established in the year 2000, the ‘Stop TB Partnership’ is mandated to eliminate Tuberculosis as a public health problem.....................

COVID-19 shouldn’t deter us from goal to eliminate TB by 2025,...

Setting the way forward, Dr Harsh Vardhan met Development Partners to discuss the challenge and opportunity in eradicating Tuberculosis by the year 2025.........................

TB a priority despite COVID-19: Dr Harsh Vardhan

Dr Harsh Vardhan, Union Minister of Health and Family Welfare has stated that the Government is committed to scaling up access to free diagnosis through rapid molecular tests, provide information on drug resistance, and also a free treatment for all people with TB with best-quality drugs.....................

Lupin launches Favipiravir drug, Covihalt for treatment of mild to moderate...

Lupin Limited has announced the launch of its Favipiravir in India under the brand name Covihalt® for the treatment of mild to moderate COVID-19...................

“Our unique doorstep delivery model goes beyond health”

In an exclusive Chat with BioVoice, Mr Sandeep Ahuja, the CEO and Co-founder of Operation ASHA shared details about how a highly cost-effective, resource-efficient, and patient-centric model developed by him have also been replicated in seven other countries....................

Mylan secures DCGI approval for its drug-resistant TB drug, Pretomanid

Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be approved in more than 40 years. The approval comes as a result of Mylan’s global collaboration with non-profit drug development partner TB Alliance..................